Literature DB >> 9533039

Chromosomal assignment of human endogenous retrovirus K (HERV-K) env open reading frames.

J Mayer1, E Meese, N Mueller-Lantzsch.   

Abstract

The haploid human genome contains at least one human endogenous retrovirus K (HERV-K) env gene displaying an open reading frame, as evidenced by the high antibody titers against HERV-K Env in germ cell tumor patients at the time of tumor detection. However, the chromosomal assignment of an intact HERV-K env sequence is complicated by the existence of 25-30 HERV-K copies per haploid human genome. Recently, we reported the application of the protein truncation test (PTT) to chromosomally assign HERV-K gag open reading frames. Here, we set out to determine the chromosomal distribution of full-length HERV-K env genes. As demonstrated by somatic hybrid mapping and the PTT, HERV-K env open reading frames were found on human chromosomes 7, 19, and Y. By sequencing chromosome-specific HERV-K env subregions, we assigned two recently reported intact HERV-K sequences on human chromosomes 7 and 19, respectively. Chromosomes 7 and 19 and the Y are furthermore candidates for harboring a putative completely intact HERV-K locus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9533039     DOI: 10.1159/000134709

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  14 in total

1.  CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2).

Authors:  Laurence Lavie; Milena Kitova; Esther Maldener; Eckart Meese; Jens Mayer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.

Authors:  Ravi Tandon; Devi SenGupta; Lishomwa C Ndhlovu; Raphaella G S Vieira; R Brad Jones; Vanessa A York; Vinicius A Vieira; Elizabeth R Sharp; Andrew A Wiznia; Mario A Ostrowski; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.

Authors:  B Berkhout; M Jebbink; J Zsíros
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Haplotype analysis of the human endogenous retrovirus locus HERV-K(HML-2.HOM) and its evolutionary implications.

Authors:  Jens Mayer; Thomas Stuhr; Katrin Reus; Esther Maldener; Milena Kitova; Friedrich Asmus; Eckart Meese
Journal:  J Mol Evol       Date:  2005-10-06       Impact factor: 2.395

5.  Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia.

Authors:  H Karlsson; S Bachmann; J Schröder; J McArthur; E F Torrey; R H Yolken
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

6.  Germ cell expression of an isolated human endogenous retroviral long terminal repeat of the HERV-K/HTDV family in transgenic mice.

Authors:  A E Casau; J E Vaughan; G Lozano; A J Levine
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Human endogenous retrovirus K homologous sequences and their coding capacity in Old World primates.

Authors:  J Mayer; E Meese; N Mueller-Lantzsch
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  HERV-K(OLD): ancestor sequences of the human endogenous retrovirus family HERV-K(HML-2).

Authors:  K Reus; J Mayer; M Sauter; H Zischler; N Müller-Lantzsch; E Meese
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Human endogenous retrovirus HERV-K14 families: status, variants, evolution, and mobilization of other cellular sequences.

Authors:  Aline Flockerzi; Stefan Burkhardt; Werner Schempp; Eckart Meese; Jens Mayer
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

10.  Human endogenous retrovirus family HERV-K(HML-5): status, evolution, and reconstruction of an ancient betaretrovirus in the human genome.

Authors:  Laurence Lavie; Patrik Medstrand; Werner Schempp; Eckart Meese; Jens Mayer
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.